Published in Am J Surg on September 07, 2008
Complications following antidotal use of intravenous lipid emulsion therapy. J Med Toxicol (2014) 1.42
Difference in Early Activation of NF-κB and MCP-1 in Acinar-Cell-Rich versus Fibrotic Human Pancreas Exposed to Surgical Trauma and Hypoxia. Gastroenterol Res Pract (2014) 0.77
Acute pancreatitis caused by pancreatic ischemia after TEVAR combined with intentional celiac artery coverage and embolization of the branches of the celiac artery. J Surg Case Rep (2017) 0.75
Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26
IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology (2002) 3.48
Genetic basis of mitochondrial function and morphology in Saccharomyces cerevisiae. Mol Biol Cell (2002) 3.27
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med (2008) 2.18
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg (2011) 2.02
Chronic pancreatitis--definition, etiology, investigation and treatment. Dtsch Arztebl Int (2013) 1.82
CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol (2012) 1.76
European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis (2013) 1.75
Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology (2009) 1.72
Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas (2011) 1.64
Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60
Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg (2009) 1.54
Interventions for necrotizing pancreatitis: summary of a multidisciplinary consensus conference. Pancreas (2012) 1.53
Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. Surgery (2010) 1.49
Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg (2011) 1.49
MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol (2012) 1.43
Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation. J Gastrointest Surg (2008) 1.41
Stimulation of Central α2 Receptors Attenuates Experimental Necrotizing Pancreatitis. Pancreas (2016) 1.38
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36
Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol (2013) 1.34
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28
Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential. PLoS One (2012) 1.25
The inner membrane protein Mdm33 controls mitochondrial morphology in yeast. J Cell Biol (2003) 1.22
Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21
Postoperative pancreatic fistula. Surgeon (2010) 1.17
Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Int J Cancer (2013) 1.15
MR imaging for diagnosing cysto-biliary fistulas in cystic echinococcosis. Eur J Radiol (2007) 1.11
Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg (2010) 1.08
Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment. J Pathol (2012) 1.08
Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg (2011) 1.08
Surgical management of severe pancreatitis including sterile necrosis. J Hepatobiliary Pancreat Surg (2002) 1.06
Management of infection in acute pancreatitis. J Hepatobiliary Pancreat Surg (2002) 1.05
Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Radiat Oncol (2013) 1.03
Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories. Ann Surg (2015) 1.02
A systematic review of localization, surgical treatment options, and outcome of insulinoma. Pancreas (2014) 1.01
Reactive oxygen species in the immune system. Int Rev Immunol (2013) 1.01
Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Int J Cancer (2014) 1.01
Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas. J Comput Assist Tomogr (2009) 1.00
Decrease in clinically relevant pancreatic fistula by coverage of the pancreatic remnant after distal pancreatectomy. Surgery (2012) 0.99
Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study. Surg Endosc (2014) 0.99
Pancreatic cancer susceptibility loci and their role in survival. PLoS One (2011) 0.98
Resection of the intrapancreatic bile duct preserving the pancreas. J Hepatobiliary Pancreat Surg (2008) 0.97
Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Oncotarget (2014) 0.96
Resection after neoadjuvant therapy for locally advanced, "unresectable" pancreatic cancer. Surgery (2012) 0.96
Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology (2003) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Autophagy and cell death signaling following dietary sulforaphane act independently of each other and require oxidative stress in pancreatic cancer. Int J Oncol (2011) 0.95
Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. J Virol (2014) 0.95
Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease? Am J Surg (2011) 0.95
Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis. BMC Cancer (2012) 0.93
Pylorus resection in partial pancreaticoduodenectomy: impact on delayed gastric emptying. Am J Surg (2013) 0.92
Value of three-dimensional reconstructions in pancreatic carcinoma using multidetector CT: initial results. World J Gastroenterol (2009) 0.92
Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg (2015) 0.92
Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. Cancer Immunol Immunother (2013) 0.92
Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor. Cell Metab (2011) 0.92
Survival data justifies resection for pancreatic metastases. Ann Surg Oncol (2009) 0.91
Uncinate process first--a novel approach for pancreatic head resection. Langenbecks Arch Surg (2010) 0.91
Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg (2014) 0.91
Surgical therapy of chronic pancreatitis: indications, techniques and results. Int J Surg (2009) 0.90
Prophylactic antibiotic treatment is superior to therapy on-demand in experimental necrotising pancreatitis. Crit Care (2008) 0.90
Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery (2012) 0.90